Raras
Buscar doenças, sintomas, genes...
Síndrome Lesch-Nyhan
ORPHA:510CID-10 · E79.1CID-11 · 5C55.01OMIM 300322DOENÇA RARA

A síndrome de Lesch-Nyhan (SLN) é a forma mais grave da falta de uma enzima chamada HPRT (hipoxantina-guanina fosforribosiltransferase), uma condição genética que afeta o metabolismo das purinas. Ela está associada à produção excessiva de ácido úrico, problemas neurológicos e problemas de comportamento.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de Lesch-Nyhan (SLN) é a forma mais grave da falta de uma enzima chamada HPRT (hipoxantina-guanina fosforribosiltransferase), uma condição genética que afeta o metabolismo das purinas. Ela está associada à produção excessiva de ácido úrico, problemas neurológicos e problemas de comportamento.

Pesquisas ativas
1 ensaio
6 total registrados no ClinicalTrials.gov
Publicações científicas
790 artigos
Último publicado: 2026 Mar 31
Medicamentos
2 registrados
SAPROPTERIN, ECOPIPAM

Tem tratamento?

2 medicamentos registrados
Ver detalhes, fases e interações →
SAPROPTERINECOPIPAM

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Spain
Início
Infancy
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: E79.1
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (6)
0202010279
Dosagem de aminoácidos (erros inatos)metabolic_test
0202010295
Dosagem de ácidos orgânicos na urinagenetic_test
0202010490
Teste de triagem para erros inatos do metabolismonewborn_screening
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202080013
Teste do pezinho (triagem neonatal)
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
10 sintomas
🫘
Rins
4 sintomas
🩸
Sangue
2 sintomas
🫃
Digestivo
2 sintomas
🦴
Ossos e articulações
2 sintomas
💪
Músculos
1 sintomas

+ 19 sintomas em outras categorias

Características mais comuns

100%prev.
Hiperuricemia
Muito frequente (99-80%)
100%prev.
Deficiência intelectual
Frequência: 2/2
100%prev.
Controle cefálico pobre
Obrigatório (100%)
100%prev.
Hipotonia
Frequência: 2/2
100%prev.
Atraso global do desenvolvimento
Frequência: 23/23
100%prev.
Início na infância
Frequência: 2/2
40sintomas
Muito frequente (14)
Frequente (6)
Ocasional (3)
Sem dados (17)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 40 características clínicas mais associadas, ordenadas por frequência.

HiperuricemiaHyperuricemia
Muito frequente (99-80%)100%
Deficiência intelectualIntellectual disability
Frequência: 2/2100%
Controle cefálico pobrePoor head control
Obrigatório (100%)100%
HipotoniaHypotonia
Frequência: 2/2100%
Atraso global do desenvolvimentoGlobal developmental delay
Frequência: 23/23100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico790PubMed
Últimos 10 anos180publicações
Pico201620 papers
Linha do tempo
2026Hoje · 2026🧪 1996Primeiro ensaio clínico📈 2016Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: X-linked recessive.

HPRT1Hypoxanthine-guanine phosphoribosyltransferaseDisease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

Converts guanine to guanosine monophosphate, and hypoxanthine to inosine monophosphate. Transfers the 5-phosphoribosyl group from 5-phosphoribosylpyrophosphate onto the purine. Plays a central role in the generation of purine nucleotides through the purine salvage pathway

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (2)
Purine salvageAzathioprine ADME
MECANISMO DE DOENÇA

Lesch-Nyhan syndrome

Characterized by complete lack of enzymatic activity that results in hyperuricemia, choreoathetosis, intellectual disability, and compulsive self-mutilation.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
128.5 TPM
Brain Frontal Cortex BA9
120.5 TPM
Testículo
116.1 TPM
Cérebro - Hemisfério cerebelar
78.0 TPM
Brain Anterior cingulate cortex BA24
66.1 TPM
OUTRAS DOENÇAS (2)
hypoxanthine guanine phosphoribosyltransferase partial deficiencyLesch-Nyhan syndrome
HGNC:5157UniProt:P00492

Medicamentos e terapias

SAPROPTERINPhase 2

Mecanismo: Phenylalanine-4-hydroxylase activator

ECOPIPAMPhase 1

Mecanismo: Dopamine D1 receptor antagonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

315 variantes patogênicas registradas no ClinVar.

🧬 HPRT1: GRCh37/hg19 Xq23-28(chrX:113417246-155233731)x1 ()
🧬 HPRT1: GRCh37/hg19 Xq26.1-26.3(chrX:128882432-134384406)x3 ()
🧬 HPRT1: NM_000194.3(HPRT1):c.609+1G>A ()
🧬 HPRT1: NM_000194.3(HPRT1):c.500G>T (p.Arg167Met) ()
🧬 HPRT1: NM_000194.3(HPRT1):c.27+174G>T ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 227 variantes classificadas pelo ClinVar.

102
68
57
Patogênica (44.9%)
VUS (30.0%)
Benigna (25.1%)
VARIANTES MAIS SIGNIFICATIVAS
HPRT1: NM_000194.3(HPRT1):c.27+174G>T [Likely pathogenic]
HPRT1: NM_000194.3(HPRT1):c.238G>T (p.Asp80Tyr) [Likely pathogenic]
HPRT1: NM_000194.3(HPRT1):c.112C>G (p.Pro38Ala) [Likely pathogenic]
HPRT1: NM_000194.3(HPRT1):c.486C>G (p.Ser162Arg) [Likely pathogenic]
HPRT1: NC_000023.11:g.134459473_134465044del [Pathogenic]

Vias biológicas (Reactome)

3 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 32
2Fase 22
1Fase 12
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 2 medicamentos · 6 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Lesch-Nyhan

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

6 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥈Melhor nível de evidência: Observacional
Timeline de publicações
112 papers (10 anos)
#1

Nonextraction solution for self-injurious behavior in children with Lesch-Nyhan syndrome: a retrospective case series with up to 14 years of follow-up.

Quintessence international (Berlin, Germany : 1985)2026 Mar 09

Lesch-Nyhan syndrome (LNS) is a rare X-linked disorder characterized by hyperuricemia, neurological impairment, and severe self-injurious behavior (SIB), frequently involving the oral tissues. Dental management of oral SIB remains challenging, and irreversible tooth extraction is still commonly employed. This retrospective case series describes four unrelated patients with LNS (aged 2.5-16 years) treated over a 20-year period using a customized dual-laminate thermoplastic intraoral appliance. The primary outcome was cessation of oral self-injury; secondary outcomes included tissue healing, appliance tolerance, and adverse effects. Follow-up ranged from 16 months to 14 years. All patients demonstrated complete clinical cessation of oral self-biting, with healing of soft tissues and no need for tooth extraction. The appliances were well tolerated, easily fabricated, and demonstrated durable performance without reported complications during long-term follow-up. This conservative, fully intraoral approach may represent an effective and reversible alternative to irreversible dental extractions for managing oral SIB in patients with LNS, particularly when implemented in experienced clinical settings. The technique appears most appropriate for dentists trained in special care or hospital-based dentistry to ensure safety, comfort, and long-term functional outcomes.

#2

When the kidneys speak for the brain: a nephrological presentation of a rare neurological disorder.

Pediatric nephrology (Berlin, Germany)2026 May

Lesch-Nyhan syndrome (LNS) is a rare X-linked recessive disorder caused by complete deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT). While the disease is classically characterized by severe neurological manifestations and self-injurious behavior, kidney involvement is an underrecognized but important aspect of the clinical spectrum.

#3

Modeling rare genetic disease with gene-edited induced pluripotent stem cells: relevance of the starting stock line.

Stem cells translational medicine2025 Nov 24

Induced pluripotent stem cells (iPSCs) are commonly used to model human genetic diseases. Two main strategies are used. The first involves making iPSC lines from individual cases with a disease, and the second involves making disease-relevant gene edits in established iPSC lines. Because generating gene-edited lines is time consuming and expensive, most studies begin with one starting iPSC stock line and evaluate several gene-edited sublines. The current studies focus on gene-editing to model Lesch-Nyhan disease (LND), which is caused by mutations in the HPRT1 gene. The same pathogenic c.508C>T edit was made in four well-established stock lines, and three gene-edited lines were isolated from each. RNA sequencing (RNAseq) was, then, used to evaluate the impact of the gene edit. Gene-edited lines were compared to their corresponding stock lines, as well as to each other. An aggregate analysis of all lines combined was also conducted to determine the most robust findings across all lines. Results from gene editing were further compared with iPSC lines derived from individual cases with LND, to determine how closely findings from gene editing match results obtained with case-derived lines. There were two main findings. First, the same gene edit has a different impact on gene expression when starting with different starting stock lines. Second, the gene editing strategy does not produce the same results as the case-derived strategy. Potential explanations for these differences are addressed, along with the relevance of these two different strategies for disease modeling.

#4

Uncovering Proteomic and Biochemical Alterations in Plasma from Lesch-Nyhan Disease Patients.

Cellular and molecular neurobiology2025 Dec 15

Lesch-Nyhan disease (LND) is an ultra-rare X-linked inborn error of metabolism caused by complete or partial deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT), a key enzyme in the purine salvage pathway. This defect leads to uric acid overproduction and a broad spectrum of neurological and behavioral manifestations, whose severity depends on the degree of residual enzymatic activity. Although emerging evidence implicates HPRT deficiency in widespread cellular dysfunctions, particularly within midbrain dopaminergic neurons, the molecular mechanisms underlying the neurobehavioral phenotype of HPRT deficiency remain poorly understood and are not adequately explained by purine metabolism dysfunctions alone. Although proteomics represents a powerful approach for elucidating molecular alterations underlying disease, it has so far found only limited application in LND research. To address this gap, we provide here the first proteomic study combined with clinical biochemistry data and pro-inflammatory cytokines profiling of plasma samples from 29 HPRT deficient individuals (21 with classic LND and 8 with Lesch-Nyhan variants - LNV). We suggest that plasma proteomics might be a potential tool in LND for monitoring disease progression and therapeutic response, potentially paving the way for targeted treatment strategies that extend beyond the purine salvage pathway to address the currently unmet clinical needs of LND patients.

#5

Association of alcohol responsiveness and non-motor symptoms in isolated adult-onset dystonia.

Journal of neurology2025 Sep 29

About 30% of patients with isolated adult-onset dystonia report an improvement of their motor symptoms after the consumption of alcohol. In this cross-sectional study, we sought to investigate whether the observed improvement is attributable to the anxiolytic, euphoric, and analgesic properties of alcohol, rather than or in addition to its effect on dystonic movements, as psychiatric symptoms and pain frequently occur in dystonia patients and as emotional stress is a well-established trigger for symptom exacerbation. We analyzed data from 339 prospectively enrolled participants with recently diagnosed isolated dystonia (mean age: 55.2 ± 12.5 years, 228 female) of the Natural History Project of the Dystonia Coalition, a large international multicenter study. Alcohol responsiveness was determined by patients´ self-report. Symptoms of depression, as well as generalized and social anxiety, were assessed using the Hospital Anxiety and Depression Scale and the Liebowitz Social Anxiety Scale. Severity of pain was measured using question 21 of the RAND 36-Item Health Survey. Participants with more severe pain reported greater response to alcohol than those with less severe pain (p = .004), whereas symptoms of depression (p = .986), generalized anxiety (p = .395) and social anxiety (p = .953) were not associated. Alcohol responsiveness in isolated dystonia is associated with higher levels of pain, whereas self-reported alcohol-related improvements in dystonic movements or tremor do not depend on the euphoric or anxiolytic effects of alcohol. This finding underscores the potential role of pain management in alleviating motor symptoms in dystonia.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC504 artigos no totalmostrando 179

2026

Nonextraction solution for self-injurious behavior in children with Lesch-Nyhan syndrome: a retrospective case series with up to 14 years of follow-up.

Quintessence international (Berlin, Germany : 1985)
2026

When the kidneys speak for the brain: a nephrological presentation of a rare neurological disorder.

Pediatric nephrology (Berlin, Germany)
2025

Umbilical Cord Blood Transplantation in Lesch-Nyhan Syndrome: A Case Report and Literature Review.

Cureus
2025

Modeling rare genetic disease with gene-edited induced pluripotent stem cells: relevance of the starting stock line.

Stem cells translational medicine
2025

Uncovering Proteomic and Biochemical Alterations in Plasma from Lesch-Nyhan Disease Patients.

Cellular and molecular neurobiology
2025

Association of alcohol responsiveness and non-motor symptoms in isolated adult-onset dystonia.

Journal of neurology
2025

Development of a Patient-Centered Outcome Tool for Blepharospasm: A Stepwise Modified Delphi Study.

Toxins
2025

Lesch-Nyhan syndrome a dental approach: case report.

African health sciences
2025

Guanine is an inhibitor of c-jun terminal kinases.

Scientific reports
2025

[Clinical characteristics and treatment of two children with Lesch-Nyhan syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

Modeling rare genetic disease with patient-derived induced pluripotent stem cells: reassessment of the minimum numbers of lines needed.

Stem cells translational medicine
2025

Gene Expression Analysis of HPRT-Deficient Cells Maintained with Physiological Levels of Folic Acid.

Cells
2025

The diagnosis and treatment of disorders of nucleic acid/nucleotide metabolism associated with epilepsy.

Acta epileptologica
2025

[Lesch-Nyhan syndrome in dizygotic twins].

Medicina
2025

Case report: Whole exome sequencing identifies a novel variant in the HPRT1 gene in a male with developmental delay.

Frontiers in genetics
2025

Purine Metabolism and Dystonia: Perspectives of a Long-Promised Relationship.

Annals of neurology
2025

The Role of Purine Metabolism and Uric Acid in Postnatal Neurologic Development.

Molecules (Basel, Switzerland)
2025

Kidney Stones in Children: Causes, Consequences, and Concerns.

Indian pediatrics
2024

Lesch-Nyhan Syndrome and Oral Self-injury: A Systematic Review of Case Reports.

International journal of clinical pediatric dentistry
2024

Whole Exome Sequencing Facilitates Early Diagnosis of Lesch-Nyhan Syndrome: A Case Series.

Diagnostics (Basel, Switzerland)
2025

Lesch-Nyhan Syndrome with Neurological Symptoms and Nephrocalcinosis.

Indian journal of pediatrics
2024

Genetic Diversity and Expanded Phenotypes in Dystonia: Insights from Large-Scale Exome Sequencing.

medRxiv : the preprint server for health sciences
2024

A narrative review of monogenic disorders causing nephrolithiasis and chronic kidney disease.

Nephrology (Carlton, Vic.)
2025

Unleashing the Power of Induced Pluripotent stem Cells in in vitro Modelling of Lesch-Nyhan Disease.

Stem cell reviews and reports
2024

Genetic Risk Factors in Isolated Dystonia Escape Genome-Wide Association Studies.

Movement disorders : official journal of the Movement Disorder Society
2024

Management of neurological symptoms in Lesch-Nyhan disease: A systematic review.

Neuroscience and biobehavioral reviews
2024

Adenylyl cyclase 2 expression and function in neurological diseases.

CNS neuroscience &amp; therapeutics
2024

Recurrent Fevers, Dysautonomia, and Dehydration in a Patient With Lesch-Nyhan Syndrome.

Cureus
2024

Duration of botulinum toxin efficacy in cervical dystonia clinical trials: A scoping review.

Parkinsonism &amp; related disorders
2024

Establishment and characterization of Lesch-Nyhan syndrome rabbit model.

Yi chuan = Hereditas
2024

Metabolic and neurobehavioral disturbances induced by purine recycling deficiency in Drosophila.

eLife
2024

A rare case of congenital insensitivity to pain with anhidrosis.

Paediatrics and international child health
2024

Very Early Levodopa May Prevent Self-Injury in Lesch-Nyhan Disease.

Pediatric neurology
2024

A Wearable Electrochemical Biosensor Utilizing Functionalized Ti3C2Tx MXene for the Real-Time Monitoring of Uric Acid Metabolite.

Analytical chemistry
2024

Amyloidogenic Propensity of Metabolites in the Uric Acid Pathway and Urea Cycle Critically Impacts the Etiology of Metabolic Disorders.

ACS chemical neuroscience
2024

An Exploratory, Randomized, Double-Blind Clinical Trial of Dipraglurant for Blepharospasm.

Movement disorders : official journal of the Movement Disorder Society
2024

A new physiological medium uncovers biochemical and cellular alterations in Lesch-Nyhan disease fibroblasts.

Molecular medicine (Cambridge, Mass.)
2023

Comments regarding the paper "Lesch-Nyhan syndrome: a case report" published recently by Park et al. in J Korean Assoc Oral Maxillofac Surg.

Journal of the Korean Association of Oral and Maxillofacial Surgeons
2024

Generation of an iPSC line (SDQLCHi030-A) derived from PBMCs of a patient with Lesch-Nyhan syndrome caused by HPRT1 mutation.

Stem cell research
2024

Naringin corrects renal failure related to Lesch-Nyhan disease in a rat model via NOS-cAMP-PKA and BDNF/TrkB pathways.

Journal of biochemical and molecular toxicology
2023

Red Blood Cells from Individuals with Lesch-Nyhan Syndrome: Multi-Omics Insights into a Novel S162N Mutation Causing Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency.

Antioxidants (Basel, Switzerland)
2023

Lesch-Nyhan syndrome: a case report.

Journal of the Korean Association of Oral and Maxillofacial Surgeons
2023

The Role of Video-EEG Monitoring in Lesch-Nyhan Syndrome.

Maedica
2023

Clinical and genetic characteristics of 36 children with Joubert syndrome.

Frontiers in pediatrics
2023

Renal function, sex and age influence purines and pyrimidines in urine and could lead to diagnostic misinterpretation.

Molecular genetics and metabolism
2023

Discovering functionally important sites in proteins.

Nature communications
2023

CRISPR/Cas9-mediated generation of human embryonic stem cell sub-lines with HPRT1 gene knockout to model Lesch Nyhan disease.

Stem cell research
2023

Half-chromatid mutation as a possible cause of mosaic males and females in Hymenoptera and rare fertile male tortoiseshell cats.

Genome
2023

[Genetic analysis of a Chinese pedigree with Lesch-Nyhan syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2023

Single-Electrode Deep Brain Stimulation of Bilateral Posterolateral Globus Pallidus Internus in Patients With Medically Resistant Lesch-Nyhan Syndrome.

Cureus
2023

Electro-optical behaviour of CuFe2 O4 @rGO nanocomposite for nonenzymatic detection of uric acid via the electrochemical method.

Luminescence : the journal of biological and chemical luminescence
2023

Therapeutic gene correction for Lesch-Nyhan syndrome using CRISPR-mediated base and prime editing.

Molecular therapy. Nucleic acids
2023

Comments regarding the paper "Oral Self-Mutilation in Lesch-Nyhan Patients: A Cross-Sectional Study" by Gaetano et al. published recently in the Journal of Clinical Medicine. 2022; 11: 5981. and concerning a topic related to pediatric dental practice.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry
2023

HPRT1 Deficiency Induces Alteration of Mitochondrial Energy Metabolism in the Brain.

Molecular neurobiology
2022

Detailed genetic and clinical analysis of a novel de novo variant in HPRT1: Case report of a female patient from Saudi Arabia with Lesch-Nyhan syndrome.

Frontiers in genetics
2023

Deep brain stimulation in Lesch-Nyhan syndrome: a systematic review.

Neurosurgical review
2022

[Analysis of HPRT1 gene variant and prenatal diagnosis for a Chinese pedigree with Lesch-Nyhan syndrome but no specimen from affected probands].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2022

Oral Self-Mutilation in Lesch-Nyhan Patients: A Cross-Sectional Study.

Journal of clinical medicine
2022

Abnormalities of neural stem cells in Lesch-Nyhan disease.

Journal of neurogenetics
2022

Monogenic urinary lithiasis in Tunisian children: 25 years' experience of a referral center.

La Tunisie medicale
2022

Teeth Mutilation: Review and Two Case Reports.

Journal of pharmacy &amp; bioallied sciences
2022

Oral Self-Mutilation in Lesch-Nyhan Syndrome: A Case Report.

Cureus
2022

Ethical implications of early genetic diagnosis in an infant with Lesch-Nyhan syndrome.

Journal of genetic counseling
2022

HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch-Nyhan disease.

Cellular and molecular life sciences : CMLS
2021

Architecture of a multi-channel and easy-to-make microfluidic paper-based colorimetric device (μPCD) towards selective and sensitive recognition of uric acid by AuNPs: an innovative portable tool for the rapid and low-cost identification of clinically relevant biomolecules.

RSC advances
2022

Liquid crystal-based sensitive and selective detection of uric acid and uricase in body fluids.

Talanta
2022

PUS7 deficiency in human patients causes profound neurodevelopmental phenotype by dysregulating protein translation.

Molecular genetics and metabolism
2022

Congenital anomalies-associated Riga-Fede disease as an early manifestation of Lesch-Nyhan syndrome: rare entities in the same pediatric patient-a case report.

BMC oral health
2022

Safety and Efficacy of Botulinum Toxin in the Treatment of Self-Biting Behavior in Lesch-Nyhan Disease.

Pediatric neurology
2021

Paroxysmal hyperthermia, dysautonomia and rhabdomyolysis in a patient with Lesch-Nyhan syndrome.

JIMD reports
2022

Microstructural white matter abnormalities in Lesch-Nyhan disease.

The European journal of neuroscience
2021

50 Years Ago in TheJournalofPediatrics: Diagnosis of Self-Mutilation and Hyperuricemia.

The Journal of pediatrics
2021

Cerebral Venous Sinus Thrombosis in a Child with Lesch-Nyhan Syndrome.

Neurology India
2021

Selecting for and Checking Cells with HGPRT Deficiency for Hybridoma Production.

Cold Spring Harbor protocols
2021

Lesch-Nyhan disease causes impaired energy metabolism and reduced developmental potential in midbrain dopaminergic cells.

Stem cell reports
2021

[Living with Lesch-Nyhan disease].

La Revue du praticien
2021

Inborn Errors of Metabolism Associated With Autism Spectrum Disorders: Approaches to Intervention.

Frontiers in neuroscience
2021

Lesch-Nyhan syndrome due to a splice-site mutation in a 14-month-old boy presenting as acute renal failure.

Clinical nephrology
2021

Induced pluripotent stem cells from subjects with Lesch-Nyhan disease.

Scientific reports
2021

Reduction of self-mutilating behavior and improved oromotor function in a patient with Lesch-Nyhan syndrome following botulinum toxin injection: A case report.

Journal of pediatric rehabilitation medicine
2021

Deep brain stimulation in Lesch-Nyhan disease: outcomes from the patient's perspective.

Developmental medicine and child neurology
2020

Recurrent Xanthine Stones in a Young Patient with Lesch-Nyhan Syndrome.

Journal of endourology case reports
2021

Oxidopamine and oxidative stress: Recent advances in experimental physiology and pharmacology.

Chemico-biological interactions
2021

Clinical and molecular findings in a Turkish family with an ultra-rare condition, ELP2-related neurodevelopmental disorder.

Molecular biology reports
2020

CT, US and MRI of xanthine urinary stones: in-vitro and in-vivo analyses.

BMC urology
2020

Atypical Cadherin FAT3 Is a Novel Mediator for Morphological Changes of Microglia.

eNeuro
2020

Hypoxanthine phosphoribosyltransferase (HPRT)-deficiency is associated with impaired fertility in the female rat.

Molecular reproduction and development
2020

Delayed emergence from propofol anesthesia in a patient with Lesch-Nyhan syndrome: A case report.

Medicine
2020

An electrochemical biosensor based on multi-wall carbon nanotube-modified screen-printed electrode immobilized by uricase for the detection of salivary uric acid.

Analytical and bioanalytical chemistry
2021

Deep Brain Stimulation of the Internal Pallidum in Lesch-Nyhan Syndrome: Clinical Outcomes and Connectivity Analysis.

Neuromodulation : journal of the International Neuromodulation Society
2020

A case of a 'rude' but not to be missed manifestation of epilepsy: ictal swearing.

The journal of the Royal College of Physicians of Edinburgh
2020

Self-injurious behaviour in movement disorders: systematic review.

Journal of neurology, neurosurgery, and psychiatry
2020

Physiological levels of folic acid reveal purine alterations in Lesch-Nyhan disease.

Proceedings of the National Academy of Sciences of the United States of America
2020

Lesch-Nyhan disease: I. Construction of expression vectors for hypoxanthine-guanine phosphoribosyltransferase (HGprt) enzyme and amyloid precursor protein (APP).

Nucleosides, nucleotides &amp; nucleic acids
2020

Animal Model Contributions to Congenital Metabolic Disease.

Advances in experimental medicine and biology
2020

HPRT-related hyperuricemia with a novel p.V35M mutation in HPRT1 presenting familial juvenile gout.

CEN case reports
2020

Rescuing compounds for Lesch-Nyhan disease identified using stem cell-based phenotypic screening.

JCI insight
2020

Late diagnosis of Lesch-Nyhan disease complicated with end-stage renal disease and tophi burst: a case report.

Renal failure
2019

Anaesthetic management of a child with Lesch Nyhan syndrome.

Indian journal of anaesthesia
2019

[Generation of cell strains containing point mutations in HPRT1 by CRISPR/Cas9].

Yi chuan = Hereditas
2019

HPRT and Purine Salvaging Are Critical for Hematopoietic Stem Cell Function.

Stem cells (Dayton, Ohio)
2019

Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.

BMJ open
2020

Reduced Graphene Oxide-based Covalent Hybrid Film Electrode Self-assembled with Gold Nanoparticles for the Enzyme-Free Amperometric Sensing of Serum Uric Acid.

Analytical sciences : the international journal of the Japan Society for Analytical Chemistry
2020

Tongue Protrusion Dystonia in Pantothenate Kinase-Associated Neurodegeneration.

Pediatric neurology
2019

Animal Models of Self-Injurious Behavior: An Update.

Methods in molecular biology (Clifton, N.J.)
2019

Clinical, biochemical and genetic characteristics of a cohort of 101 French and Italian patients with HPRT deficiency.

Molecular genetics and metabolism
2019

Phenotypic and molecular spectrum of Korean patients with Lesch-Nyhan syndrome and attenuated clinical variants.

Metabolic brain disease
2019

Dystonia in Handcuffs: A Picture Typical of Lesch-Nyhan Syndrome.

Movement disorders clinical practice
2019

Microglial histamine H4R in the pathophysiology of Parkinson's disease-a new actor on the stage?

Naunyn-Schmiedeberg's archives of pharmacology
2019

Genetic mimics of cerebral palsy.

Movement disorders : official journal of the Movement Disorder Society
2019

Understanding the structure-function relationship of HPRT1 missense mutations in association with Lesch-Nyhan disease and HPRT1-related gout by in silico mutational analysis.

Computers in biology and medicine
2020

Analysis of synonymous codon usage patterns of HPRT1 gene across twelve mammalian species.

Genomics
2019

Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: Preliminary in vitro studies with analogues of immucillin-G.

Journal of inherited metabolic disease
2020

Spinal Tophi Causing Cord Compression and Mimicking Epidural Abscess in a Young Man With Lesch-Nyhan Variant.

Journal of clinical rheumatology : practical reports on rheumatic &amp; musculoskeletal diseases
2019

Recurrent kidney stones in a child with Lesch-Nyhan syndrome: Answers.

Pediatric nephrology (Berlin, Germany)
2019

Recurrent kidney stones in a child with Lesch-Nyhan syndrome: Questions.

Pediatric nephrology (Berlin, Germany)
2018

Compositional complexity of rods and rings.

Molecular biology of the cell
2018

Xanthine calculi in a patient with Lesch-Nyhan syndrome and factor V Leiden treated with allopurinol: case report.

BMC pediatrics
2018

Congenital and acquired diseases related to stone formation.

Current opinion in urology
2018

GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.

International journal of rheumatic diseases
2019

Macrocytic anemia in Lesch-Nyhan disease and its variants.

Genetics in medicine : official journal of the American College of Medical Genetics
2018

A review of HPRT and its emerging role in cancer.

Medical oncology (Northwood, London, England)
2018

Oral self-mutilation in Lesch-Nyhan Syndrome. Case Report.

Revista chilena de pediatria
2018

Inborn Errors of Metabolism with Cognitive Impairment: Metabolism Defects of Phenylalanine, Homocysteine and Methionine, Purine and Pyrimidine, and Creatine.

Pediatric clinics of North America
2018

Lesch-Nyhan Syndrome in a Chinese Family with Mutation in the Hypoxanthine-Guanine Phosphoribosyltransferase Gene.

Clinical laboratory
2018

Leveraging Rational Protein Engineering to Improve mRNA Therapeutics.

Nucleic acid therapeutics
2018

Altered gastrointestinal motility in an animal model of Lesch-Nyhan disease.

Autonomic neuroscience : basic &amp; clinical
2018

Lesch-Nyhan syndrome and its variants: examining the behavioral and neurocognitive phenotype.

Current opinion in psychiatry
2017

Novel mutation in the human HPRT1 gene and the Lesch-Nyhan disease.

Nucleosides, nucleotides &amp; nucleic acids
2017

Skewed X inactivation in Lesch-Nyhan disease carrier females.

Journal of human genetics
2017

Uric acid, an important screening tool to detect inborn errors of metabolism: a case series.

BMC research notes
2017

A Case of Attempted Bilateral Self-Enucleation in a Patient with Bipolar Disorder.

Mental illness
2017

CRISPR/Cas9-Mediated Scanning for Regulatory Elements Required for HPRT1 Expression via Thousands of Large, Programmed Genomic Deletions.

American journal of human genetics
2017

Lesch-Nyhan disease in two families from Chiloé Island with mutations in the HPRT1 gene.

Nucleosides, nucleotides &amp; nucleic acids
2017

A Trivalent Enzymatic System for Uricolytic Therapy of HPRT Deficiency and Lesch-Nyhan Disease.

Pharmaceutical research
2017

Lesch-Nyhan syndrome: The saga of metabolic abnormalities and self-injurious behavior.

Intractable &amp; rare diseases research
2017

The renal phenotype of allopurinol-treated HPRT-deficient mouse.

PloS one
2017

Quantification of various APP-mRNA isoforms and epistasis in Lesch-Nyhan disease.

Neuroscience letters
2016

Oral Hemorrhage in a 3-year-old Boy Caused by Self-Mutilating Behavior.

Pakistan journal of medical sciences
2017

Human HPRT1 gene and the Lesch-Nyhan disease: Substitution of alanine for glycine and inversely in the HGprt enzyme protein.

Nucleosides, nucleotides &amp; nucleic acids
2017

[Treatment of self-injurious behaviors in Lesch-Nyhan syndrome with S-adenosylmethionine].

No to hattatsu = Brain and development
2016

Lesch-Nyhan Syndrome: Models, Theories, and Therapies.

Molecular syndromology
2016

A review of the implication of hypoxanthine excess in the physiopathology of Lesch-Nyhan disease.

Nucleosides, nucleotides &amp; nucleic acids
2016

Development of new forms of self-injurious behavior following total dental extraction in Lesch-Nyhan disease.

Nucleosides, nucleotides &amp; nucleic acids
2016

Self-injurious Behavior in a Young Child with Lesch-Nyhan Syndrome.

Indian journal of psychological medicine
2017

Novel mutation in HPRT1 causing a splicing error with multiple variations.

Nucleosides, nucleotides &amp; nucleic acids
2016

HPRTYale proposed as a pathogenic variant for Lesch-Nyhan syndrome: a case report.

Genetics and molecular research : GMR
2016

Mutation in the Human HPRT1 Gene and the Lesch-Nyhan Syndrome.

Nucleosides, nucleotides &amp; nucleic acids
2016

Lesch-Nyhan Syndrome: Disorder of Self-mutilating Behavior.

International journal of clinical pediatric dentistry
2016

Towards rational drug treatment of Lesch-Nyhan disease.

Molecular genetics and metabolism
2016

Neurotransmitter and their metabolite concentrations in different areas of the HPRT knockout mouse brain.

Journal of the neurological sciences
2016

Acute renal failure unmasking Lesch-Nyhan disease in a patient with tuberous sclerosis complex.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2016

Reduced levels of dopamine and altered metabolism in brains of HPRT knock-out rats: a new rodent model of Lesch-Nyhan Disease.

Scientific reports
2016

A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease.

Molecular genetics and metabolism
2016

Overcoming the oral aspects of -self-mutilation: description of a method.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2016

Nephrocalcinosis and Renal Failure in Lesch-Nyhan Syndrome: Report of Two Familial Cases and Review of the Literature.

Urology
2016

The Use of Perinatal 6-Hydroxydopamine to Produce a Rodent Model of Lesch-Nyhan Disease.

Current topics in behavioral neurosciences
2016

A clinical trial of safety and tolerability for the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease.

Molecular genetics and metabolism
2016

The eye and the skin in nonendocrine metabolic disorders.

Clinics in dermatology
2016

[Self injury in adolescence].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
2017

An unusual case of renal failure: Answers.

Pediatric nephrology (Berlin, Germany)
2017

An unusual case of renal failure: Questions.

Pediatric nephrology (Berlin, Germany)
2015

Altered histamine neurotransmission in HPRT-deficient mice.

Neuroscience letters
2015

Epigenetic Regulation in Amyloid Precursor Protein with Genomic Rearrangements and the Lesch-Nyhan Syndrome.

Nucleosides, nucleotides &amp; nucleic acids
2015

MicroRNAs: tools of mechanistic insights and biological therapeutics discovery for the rare neurogenetic syndrome Lesch-Nyhan disease (LND).

Advances in genetics
2015

Determination of Activity of the Enzymes Hypoxanthine Phosphoribosyl Transferase (HPRT) and Adenine Phosphoribosyl Transferase (APRT) in Blood Spots on Filter Paper.

Current protocols in human genetics
2015

Lesch-Nyhan Syndrome in an Indian Child.

Indian journal of dermatology
2016

Do clinical features of Lesch-Nyhan disease correlate more closely with hypoxanthine or guanine recycling?

Journal of inherited metabolic disease
2015

Efficient Gene Editing in Pluripotent Stem Cells by Bacterial Injection of Transcription Activator-Like Effector Nuclease Proteins.

Stem cells translational medicine
2015

Lesch-Nyhan Syndrome in a Family with a Deletion Followed by an Insertion within the HPRT1 Gene.

Nucleosides, nucleotides &amp; nucleic acids
2015

Hypoxanthine deregulates genes involved in early neuronal development. Implications in Lesch-Nyhan disease pathogenesis.

Journal of inherited metabolic disease
2015

Nucleotide salvage deficiencies, DNA damage and neurodegeneration.

International journal of molecular sciences
2015

Angelman syndrome: The blurred lines of interpretation in cognitive defects.

Journal of pediatric neurosciences
2015

Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease.

Molecular genetics and metabolism
2015

Small Duplication of HPRT 1 Gene May Be Causative For Lesh-Nyhan Disease in Iranian Patients.

Iranian journal of child neurology
2015

The human β-amyloid precursor protein: biomolecular and epigenetic aspects.

Biomolecular concepts
2015

Alzheimer's disease shares gene expression aberrations with purinergic dysregulation of HPRT deficiency (Lesch-Nyhan disease).

Neuroscience letters
2015

New biomarkers for early diagnosis of Lesch-Nyhan disease revealed by metabolic analysis on a large cohort of patients.

Orphanet journal of rare diseases
2015

Remarkable clinical improvement with bilateral globus pallidus internus deep brain stimulation in a case of Lesch-Nyhan disease: five-year follow-up.

Neuromodulation : journal of the International Neuromodulation Society
Ver todos os 504 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Lesch-Nyhan.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Lesch-Nyhan

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Nonextraction solution for self-injurious behavior in children with Lesch-Nyhan syndrome: a retrospective case series with up to 14 years of follow-up.
    Quintessence international (Berlin, Germany : 1985)· 2026· PMID 41797617mais citado
  2. When the kidneys speak for the brain: a nephrological presentation of a rare neurological disorder.
    Pediatric nephrology (Berlin, Germany)· 2026· PMID 41501258mais citado
  3. Modeling rare genetic disease with gene-edited induced pluripotent stem cells: relevance of the starting stock line.
    Stem cells translational medicine· 2025· PMID 41400570mais citado
  4. Uncovering Proteomic and Biochemical Alterations in Plasma from Lesch-Nyhan Disease Patients.
    Cellular and molecular neurobiology· 2025· PMID 41398526mais citado
  5. Association of alcohol responsiveness and non-motor symptoms in isolated adult-onset dystonia.
    Journal of neurology· 2025· PMID 41016940mais citado
  6. Recurrent Oral Ulcers and Self-Mutilation in Infancy: Distinguishing Congenital Insensitivity to Pain with Anhidrosis from Lesch-Nyhan Syndrome.
    Indian J Pediatr· 2026· PMID 41915345recente
  7. Umbilical Cord Blood Transplantation in Lesch-Nyhan Syndrome: A Case Report and Literature Review.
    Cureus· 2025· PMID 41416282recente
  8. Lesch-Nyhan syndrome a dental approach: case report.
    Afr Health Sci· 2025· PMID 40837648recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:510(Orphanet)
  2. OMIM OMIM:300322(OMIM)
  3. MONDO:0010298(MONDO)
  4. GARD:7226(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q727436(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Lesch-Nyhan
Compêndio · Raras BR

Síndrome Lesch-Nyhan

ORPHA:510 · MONDO:0010298
Prevalência
1-9 / 1 000 000
Herança
X-linked recessive
CID-10
E79.1 · Síndrome de Lesch-Nyhan
CID-11
Ensaios
1 ativos
Medicamentos
2 registrados
Início
Infancy
Prevalência
0.0 (Spain)
MedGen
UMLS
C0023374
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades